Dagmar Rosa-Bjorkeson

Dagmar Rosa-Bjorkeson

Directeur/Membre du Conseil chez
Deirdres House
62 ans
Health Technology
Consumer Services

Profil

Dagmar Rosa-Bjorkeson currently works at New Jersey City University Foundation, as Director and Deirdres House, as Director.
Ms. Rosa-Bjorkeson also formerly worked at Intercept Pharmaceuticals, Inc., as Independent Director from 2021 to 2023, Xencor, Inc., as Independent Director from 2019 to 2025, Baxalta, Inc., as President-Biosimilars & EVP from 2014 to 2016, Novartis Pharmaceuticals Corp., as Vice President & Head-Multiple Sclerosis Business from 1997 to 2014, Hoechst Pharmaceuticals Ltd., as Sales Representative, Mallinckrodt Medical, Inc. (US), as Executive VP, Chief Strategy & Development Officer from 2017 to 2020, Novartis Sverige AB, as President, Mallinckrodt Plc, as Chief Strategy & Corporate Development Officer from 2018 to 2020, and Mesoblast Ltd., as Chief Operating Officer from 2020 to 2024.
Ms. Rosa-Bjorkeson received her undergraduate degree, graduate degree, and Masters Business Admin degree from The University of Texas at Austin.

Postes actifs de Dagmar Rosa-Bjorkeson

SociétésPosteDébut
Deirdres House
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Dagmar Rosa-Bjorkeson

SociétésPosteFin
XENCOR, INC. Directeur/Membre du Conseil 12/06/2025
MESOBLAST LIMITED Directeur des opérations 01/12/2024
INTERCEPT PHARMACEUTICALS, INC. Directeur/Membre du Conseil 08/11/2023
MALLINCKRODT PLC Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/01/2020
Voir l'expérience en détail de Dagmar Rosa-Bjorkeson

Formation de Dagmar Rosa-Bjorkeson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

76

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Hoechst Pharmaceuticals Ltd.

Health Technology

Health Technology

Consumer Services

Deirdres House

  1. Bourse
  2. Insiders
  3. Dagmar Rosa-Bjorkeson
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT